Terms: = Leukemia AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476 AND Prognosis
15 results:
1. [FLT3-ITD and NPM1 mutation positive acute myeloid leukemia with cuplike blasts mimicking acute promyelocytic leukemia].
Aoyama K; Yamasaki Y; Mouri F; Maehiro Y; Takaki Y; Oya S; Nakamura T; Morishige S; Yamaguchi M; Nagafuji K
Rinsho Ketsueki; 2022; 63(7):764-769. PubMed ID: 35922945
[TBL] [Abstract] [Full Text] [Related]
2. Companion gene mutations and their clinical significance in AML with double mutant CEBPA.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Teng W; Cao P; Nie D; Ma X; Wang T; Lu P; Liu H
Cancer Gene Ther; 2020 Aug; 27(7-8):599-606. PubMed ID: 31477806
[TBL] [Abstract] [Full Text] [Related]
3. [A long-term follow-up study of 82 children with acute myeloid leukemia].
Ruan M; Qi BQ; Liu F; Liu TF; Liu XM; Chen XJ; Yang WY; Guo Y; Zhang L; Zou Y; Chen YM; Zhu XF
Zhonghua Er Ke Za Zhi; 2018 Oct; 56(10):730-734. PubMed ID: 30293275
[No Abstract] [Full Text] [Related]
4. Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance.
Zhang J; Wang Y; Wang J; Hu J; Chen S; Jin J; Liu T; Zhou J; Hu Y; Ma D; Huang X; Ji C; Hou M
Blood Cancer J; 2018 Jun; 8(7):61. PubMed ID: 29915172
[TBL] [Abstract] [Full Text] [Related]
5. Intravoxel incoherent motion diffusion-weighted imaging of bone marrow in patients with acute myeloid leukemia: a pilot study of prognostic value.
Niu J; Li W; Wang H; Wu W; Gong T; Huang N; Wang J; Qi Y
J Magn Reson Imaging; 2017 Aug; 46(2):476-482. PubMed ID: 28211619
[TBL] [Abstract] [Full Text] [Related]
6. Significance of ATM Gene Polymorphisms in Chronic Myeloid leukemia - a Case Control Study from India.
Gorre M; Mohandas PE; Kagita S; Cingeetham A; Vuree S; Jarjapu S; Nanchari S; Meka PB; Annamaneni S; Dunna NR; Digumarti R; Satti V
Asian Pac J Cancer Prev; 2016; 17(2):815-21. PubMed ID: 26925685
[TBL] [Abstract] [Full Text] [Related]
7. Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study.
Frederiksen H; Farkas DK; Christiansen CF; Larsen TS; Hasselbalch HC; Stentoft J; Sørensen HT
Lancet Haematol; 2015 Jul; 2(7):e289-96. PubMed ID: 26688384
[TBL] [Abstract] [Full Text] [Related]
8. [Survival and prognosis of patients with polycythemia vera: a study of 816 patients in a single Chinese center].
Bai J; Shi H; Ai L; Zhang L; Zhou Y; Li Z; Zhao Y; Sheng M; Li D; Li H; Qian L; Mi Y; Xiao Z; Zheng Y; Yang R; Xue Y
Zhonghua Yi Xue Za Zhi; 2015 May; 95(18):1364-8. PubMed ID: 26178350
[TBL] [Abstract] [Full Text] [Related]
9. [Prognostic significance of new biological markers in chronic lymphocytic leukaemia].
Leković D; Mihaljević B; Kraguljac-Kurtović N; Perunčić-Jovanović M; Bogdanović A; Čolović M; Gotić M
Srp Arh Celok Lek; 2011; 139(11-12):753-8. PubMed ID: 22338471
[TBL] [Abstract] [Full Text] [Related]
10. [Clinical significance of serum NGF level and CD271 expression in patients with acute B lymphoid leukemia].
Han XH; Xu KL; Zeng LY; Li ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1273-6. PubMed ID: 22040987
[TBL] [Abstract] [Full Text] [Related]
11. Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia.
Vázquez I; Maicas M; Cervera J; Agirre X; Marin-Béjar O; Marcotegui N; Vicente C; Lahortiga I; Gomez-Benito M; Carranza C; Valencia A; Brunet S; Lumbreras E; Prosper F; Gómez-Casares MT; Hernández-Rivas JM; Calasanz MJ; Sanz MA; Sierra J; Odero MD
Haematologica; 2011 Oct; 96(10):1448-56. PubMed ID: 21750091
[TBL] [Abstract] [Full Text] [Related]
12. IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.
Thol F; Weissinger EM; Krauter J; Wagner K; Damm F; Wichmann M; Göhring G; Schumann C; Bug G; Ottmann O; Hofmann WK; Schlegelberger B; Ganser A; Heuser M
Haematologica; 2010 Oct; 95(10):1668-74. PubMed ID: 20494930
[TBL] [Abstract] [Full Text] [Related]
13. Survival patterns among lymphoma patients with a family history of lymphoma.
Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O
J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984
[TBL] [Abstract] [Full Text] [Related]
14. Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations.
Lin P; Chen L; Luthra R; Konoplev SN; Wang X; Medeiros LJ
Mod Pathol; 2008 Aug; 21(8):1029-36. PubMed ID: 18536654
[TBL] [Abstract] [Full Text] [Related]
15. Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.
Armand P; Kim HT; DeAngelo DJ; Ho VT; Cutler CS; Stone RM; Ritz J; Alyea EP; Antin JH; Soiffer RJ
Biol Blood Marrow Transplant; 2007 Jun; 13(6):655-64. PubMed ID: 17531775
[TBL] [Abstract] [Full Text] [Related]
